AbbVie axes multi-billion cancer flop Rova-T after another trial failsAbbVie has axed its troubled lung cancer drug Rova-T, after another trial failure from the drug that is Share XAbbVie axes multi-billion cancer flop Rova-T after another trial failshttps://pharmaphorum.com/news/abbvie-axes-multi-billion-cancer-flop-rova-t-after-another-trial-fails/
Opdivo and Keytruda approved in new lung cancer usesThe FDA has approved Merck’s Keytruda (pembrolizumab) as a combination treatment for metastatic nonsquamous non-small cell lung cancer Share XOpdivo and Keytruda approved in new lung cancer useshttps://pharmaphorum.com/news/bmss-opdivo-approved-lung-cancer/
